About
Slaoui spent nearly 30 years leading GSK vaccines R&D—overseeing more than a dozen vaccines—served as chief scientific adviser to Operation Warp Speed, and takes hands-on chief scientific roles while investing.
Invests in
BiotechHealthtechMedical Devices
Deals · 4
Altesa BioSciencesBoard seat
via Medicxi · filed Feb 2026 · $75M raise
Curevo, Inc.Board seat
via Medicxi · filed Mar 2025 · $84.8M raise
Attribution from SEC filings, press coverage, and firm rosters.